
WestRiver Group
Description
WestRiver Group is a prominent Seattle-based investment firm, renowned for providing integrated capital solutions across the global innovation economy. The firm employs a flexible investment strategy, deploying capital across multiple asset classes including venture capital, growth equity, and private equity. This multi-stage approach allows WestRiver Group to partner with companies from their early growth phases through to more mature stages, offering tailored financial and strategic support. Founded by Erik Anderson, the firm emphasizes long-term partnerships and an active, hands-on approach with its portfolio companies.
The firm's investment focus spans several high-growth sectors, primarily technology, life sciences, and healthcare, with a growing presence in sports and media. WestRiver Group seeks out innovative companies poised for significant market disruption and sustainable growth. Their portfolio reflects a commitment to backing visionary entrepreneurs and leveraging their extensive network and operational expertise to accelerate company development. They are known for their collaborative style, working closely with management teams to navigate challenges and capitalize on opportunities.
Financially, WestRiver Group has demonstrated substantial capacity and reach. The firm has deployed over $1.5 billion of capital across its various investments, underscoring its significant footprint in the investment landscape. A notable milestone includes the closing of WestRiver Capital II, a $200 million fund, in 2019, further solidifying their ability to support ambitious ventures. This robust financial backing, combined with their strategic insights, positions WestRiver Group as a valuable partner for companies seeking not just capital, but also guidance for scaling and achieving market leadership.
Investor Profile
WestRiver Group has backed more than 45 startups, with 1 new investments in the last 12 months alone. The firm has led 23 rounds, about 51% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Software, SaaS, Biotechnology.
- Typical check size: $5M – $50M.
Stage Focus
- Series B (22%)
- Series C (20%)
- Seed (16%)
- Series Unknown (13%)
- Series D (11%)
- Series A (7%)
- Convertible Note (4%)
- Debt Financing (2%)
- Pre Seed (2%)
- Series E (2%)
Country Focus
- United States (100%)
Industry Focus
- Software
- Saas
- Biotechnology
- Health Care
- Medical
- Information Technology
- Wellness
- Life Science
- Fintech
- Dietary Supplements
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.